Scotia Capital Inc. Coh Bar, Inc. Transaction History

Scotia Capital Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 05, 2022	SELL	$0.17 - $0.34 $2,163 - $4,326	-12,726 Closed	0 $0
Q1 2022 May 09, 2022	SELL	$0.25 - $0.43 $318 - $547	-1,274 Reduced 9.1%	12,726 $4,000
Q4 2021 Feb 11, 2022	SELL	$0.34 - $1.0 $59 - $175	-175 Reduced 1.23%	14,000 $5,000
Q3 2021 Nov 12, 2021	BUY	$0.96 - $1.62 $168 - $283	175 Added 1.25%	14,175 $14,000
Q1 2021 May 06, 2021	SELL	$1.26 - $2.02 $225 - $361	-179 Reduced 1.26%	14,000 $19,000
Q4 2020 Feb 11, 2021	BUY	$0.9 - $1.54 $440 - $753	489 Added 3.57%	14,179 $19,000
Q3 2020 Nov 12, 2020	SELL	$0.87 - $2.08 $269 - $644	-310 Reduced 2.21%	13,690 $13,000
Q3 2019 Nov 14, 2019	SELL	$1.3 - $1.76 $20,800 - $28,160	-16,000 Reduced 53.33%	14,000 $18,000
Q3 2018 Nov 14, 2018	BUY	$4.13 - $6.84 $123,900 - $205,200	30,000 New	30,000 $129,000

1.14K

Ticker CWBR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,906,940
Market Cap $1.57M
Description
CohBar, Inc., a clinical stage biotechnology company, focuses in the research and development of mitochondria based therapeutics (MBTs) for the treatment of chronic and age-related diseases. The company develops MBTs to treat non-alcoholic steatohepatitis (NASH), obesity, fatty liver disease, idiopathic pulmonary fibrosis, type 2 diabetes, acute...

Get notified when there are updates to the investment portfolio of Scotia Capital Inc., based on Form 13F filings with the SEC.

Stay updated on Scotia Capital Inc. with notifications on news.